Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1569)
All Articles published online
|
Feb 28, 2007 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Soultati AS, Dourakis SP, Alexopoulou A, Deutsch M, Archimandritis AJ. Simultaneous development of diabetic ketoacidosis and Hashitoxicosis in a patient treated with pegylated interferon-alpha for chronic hepatitis C. World J Gastroenterol 2007; 13(8): 1292-1294 [PMID: 17451219 DOI: 10.3748/wjg.v13.i8.1292] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i8/1292.htm |
| Number | Citing Articles |
| 1 |
Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 2007; 16(11) doi: 10.1002/pds.1377
|
| 2 |
Xian-Ling Wang, Yi-Ming Mu, Zhao-Hui Lu, Ju-Ming Lu, Jing-Tao Dou, Chang-Yu Pan. Type 1 Diabetes Caused by Interferon α-2α in Polycythemia Vera Therapy. Diabetes Care 2010; 33(11): e141 doi: 10.2337/dc10-1266
|
| 3 |
Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 2008; 15(2): 193 doi: 10.1097/MED.0b013e3282fba8b4
|
| 4 |
Current World Literature. Current Opinion in Endocrinology, Diabetes & Obesity 2007; 14(5): 421 doi: 10.1097/MED.0b013e3282f0ca40
|
| 5 |
Simona Cristina (Nicolescu) Marinescu, Miruna-Maria Apetroaei, Marina Ionela (Ilie) Nedea, Andreea Letiția Arsene, Bruno Ștefan Velescu, Sorina Hîncu, Emilia Stancu, Anca Lucia Pop, Doina Drăgănescu, Denisa Ioana Udeanu. Dietary Influence on Drug Efficacy: A Comprehensive Review of Ketogenic Diet–Pharmacotherapy Interactions. Nutrients 2024; 16(8): 1213 doi: 10.3390/nu16081213
|
| 6 |
Paola Tarabini-Castellani, Leire Apraiz, Joseba Portu, José Manuel Agud. Diabetes mellitus en relación con tratamiento con interferón. Enfermedades Infecciosas y Microbiología Clínica 2008; 26(2): 120 doi: 10.1157/13115550
|
| 7 |
Marna G. Bouwhuis, Stefan Suciu, Alessandro Testori, Wim H. Kruit, François Salès, Poulam Patel, Cornelis J. Punt, Mario Santinami, Alain Spatz, Timo L.M. ten Hagen, Alexander M.M. Eggermont. Phase III Trial Comparing Adjuvant Treatment With Pegylated Interferon Alfa-2b Versus Observation: Prognostic Significance of Autoantibodies—EORTC 18991. Journal of Clinical Oncology 2010; 28(14): 2460 doi: 10.1200/JCO.2009.24.6264
|
| 8 |
Yuan-Yuan Lv, Bing-Yin Shi, Hui Guo. Abrupt onset of type 1 diabetes mellitus during recombinant interferon-alpha 2b therapy in a patient with chronic hepatitis B. World Journal of Gastroenterology 2008; 14(29): 4713-4715 doi: 10.3748/wjg.14.4713
|
| 9 |
Corrado Betterle, Fabio Presotto. HCV Infection and Cryoglobulinemia. 2012; : 43 doi: 10.1007/978-88-470-1705-4_5
|
| 10 |
Hiroaki Yagyu, Kenta Okada, Shin Sato, Yumiko Yamashita, Nobukazu Okada, Jun-ichi Osuga, Shoichiro Nagasaka, Kentaro Sugano, Shun Ishibashi. Pegylated interferon-α2b and ribavirin combination therapy induces Hashitoxicosis followed by type 1 diabetes mellitus. Diabetes Research and Clinical Practice 2012; 95(3): e52 doi: 10.1016/j.diabres.2011.11.016
|
| 11 |
Maria Xenou, Ioannis Zoupas, Dimitrios Lygnos, Evangelos Fousteris. Diabetic ketoacidosis as first presentation of latent autoimmune diabetes in adults in a patient with hashitoxicosis as first presentation of Hashimoto’s thyroiditis: a case report. Journal of Medical Case Reports 2022; 16(1) doi: 10.1186/s13256-022-03523-3
|
| 12 |
Yun Nah Lee, Soung Won Jeong, Jae Hee Lim, Yang Seon Ryu, Seong Ran Jeon, Sang Kyun Kim, Jae Young Jang, Young Seok Kim, Boo Sung Kim, Mi Oh Roh. Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C. The Korean Journal of Hepatology 2010; 16(2): 187 doi: 10.3350/kjhep.2010.16.2.187
|
| 13 |
Reiko Oka, Naoki Hiroi, Rika Shigemitsu, Mariko Sue, Yasuo Oshima, Mayumi Yoshida-Hiroi. Type 1 Diabetes Mellitus Associated with Pegylated Interferon-α Plus Ribavirin Treatment for Chronic Hepatitis C: Case Report and Literature Review. Clinical Medicine Insights: Endocrinology and Diabetes 2011; 4: CMED.S7815 doi: 10.4137/CMED.S7815
|
| 14 |
Daniel Lewis, Corinna van den Heuvel, Michaela Kenneally, Roger W Byard. Methamphetamine use and the risk of diabetic ketoacidosis. Medicine, Science and the Law 2022; 62(1): 39 doi: 10.1177/00258024211020936
|
| 15 |
Masayuki Hayashi, Yuko Kataoka, Kazushige Tachikawa, Hiroki Koguchi, Hiroshi Tanaka. Dual onset of type 1 diabetes mellitus and Graves’ disease during treatment with pegylated interferon α-2b and ribavirin for chronic hepatitis C. Diabetes Research and Clinical Practice 2009; 86(2): e19 doi: 10.1016/j.diabres.2009.08.009
|
| 16 |
Linghuan Wang, Kang Chen, Meirong Wang, Zhaohui Lv, Weijun Gu, Xianling Wang, Qi Ni, Yiming Mu. Characteristics of Interferon-Associated Diabetes Mellitus in Past 30 Years: A Review. Hormone and Metabolic Research 2022; 54(03): 145 doi: 10.1055/a-1749-5716
|
| 17 |
Linghuan Wang, Binqi Li, He Zhao, Peixin Wu, Qingzhen Wu, Kang Chen, Yiming Mu. A systematic review and meta-analysis of endocrine-related adverse events associated with interferon. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.949003
|
| 18 |
Taiba Zornitzki, Stephen Malnick, Lyudmila Lysyy, Hilla Knobler. Interferon therapy in hepatitis C leading to chronic type 1 diabetes. World Journal of Gastroenterology 2015; 21(1): 233-239 doi: 10.3748/wjg.v21.i1.233
|